LabCare: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LabCare
Largest movements
- Deferred charges and accrued income +€26,505
up €26,505 (+74.8%), from €35,437 to €61,942
- Cash +€16,807
up €16,807 (+32.3%), from €52,008 to €68,815
mainly Net result for the year (+€69,134) and Depreciation (+€2,175)
- Receivables within one year +€12,977
new in 2025: €12,977
- Tangible fixed assets +€2,637
up €2,637 (+37.6%), from €7,015 to €9,652
of which Other tangible fixed assets: +€1,766
- Reserves +€69,134
up €69,134 (+94.1%), from €73,440 to €142,574
- Tax, wage and social debts -€6,998
down €6,998 (-47.7%), from €14,679 to €7,681
- Other debts -€3,194
no longer reported in 2025 (was €3,194)
- Gross operating margin -€5,053
down €5,053 (-4.8%), from €106,336 to €101,283
- Taxes -€1,336
down €1,336 (-4.6%), from €28,893 to €27,558
- Financial charges +€1,208
up €1,208 (+99.0%), from €1,221 to €2,429
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €94,460 | €153,386 | +€58,926 | +62.4% |
| Fixed assets | 21/28 | €7,015 | €9,652 | +€2,637 | +37.6% |
| Tangible fixed assets | 22/27 | €7,015 | €9,652 | +€2,637 | +37.6% |
| Plant, machinery and equipment | 23 | €4,102 | €3,590 | -€512 | -12.5% |
| Furniture and vehicles | 24 | €2,913 | €4,296 | +€1,383 | +47.5% |
| Other tangible fixed assets | 26 | - | €1,766 | +€1,766 | |
| Current assets | 29/58 | €87,445 | €143,734 | +€56,289 | +64.4% |
| Amounts receivable within one year | 40/41 | - | €12,977 | +€12,977 | |
| Other amounts receivable | 41 | - | €12,977 | +€12,977 | |
| Cash at bank and in hand | 54/58 | €52,008 | €68,815 | +€16,807 | +32.3% |
| Deferred charges and accrued income | 490/1 | €35,437 | €61,942 | +€26,505 | +74.8% |
| Total equity and liabilities | 10/49 | €94,460 | €153,386 | +€58,926 | +62.4% |
| Equity | 10/15 | €76,440 | €145,574 | +€69,134 | +90.4% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €73,440 | €142,574 | +€69,134 | +94.1% |
| Distributable reserves | 133 | €73,440 | €142,574 | +€69,134 | +94.1% |
| Amounts payable | 17/49 | €18,020 | €7,812 | -€10,208 | -56.7% |
| Amounts payable within one year | 42/48 | €18,020 | €7,812 | -€10,208 | -56.7% |
| Trade debts | 44 | €147 | €130 | -€17 | -11.5% |
| Suppliers | 440/4 | €147 | €130 | -€17 | -11.5% |
| Taxes, remuneration and social security | 45 | €14,679 | €7,681 | -€6,998 | -47.7% |
| Taxes | 450/3 | €14,679 | €7,681 | -€6,998 | -47.7% |
| Other amounts payable | 47/48 | €3,194 | - | -€3,194 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,782 | €2,175 | -€607 | -21.8% |
| Gross operating margin | 9900 | €106,336 | €101,283 | -€5,053 | -4.8% |
| Operating profit (loss) | 9901 | €103,554 | €99,108 | -€4,446 | -4.3% |
| Financial income | 75/76B | - | €13 | +€13 | |
| Recurring financial income | 75 | - | €13 | +€13 | |
| Financial charges | 65/66B | €1,221 | €2,429 | +€1,208 | +99.0% |
| Recurring financial charges | 65 | €1,221 | €2,429 | +€1,208 | +99.0% |
| Profit (loss) for the period before taxes | 9903 | €102,333 | €96,692 | -€5,641 | -5.5% |
| Income taxes | 67/77 | €28,893 | €27,558 | -€1,336 | -4.6% |
| Profit (loss) for the period | 9904 | €73,440 | €69,134 | -€4,306 | -5.9% |
| Profit (loss) for the period to be appropriated | 9905 | €73,440 | €69,134 | -€4,306 | -5.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.